| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 110,952 | 135,215 | 89,674 | 65,855 | | Cost of Revenue | (6,114) | 3,232 | 2,882 | 293,542 | | | Gross Profit | 117,066 | 131,983 | 86,792 | (227,687) | | | Operating Expenses | | Research Development |
-
| (4,445) | 4,445 |
-
| | Selling General and Administrative | 110,201 | 111,513 | 73,011 | (208,855) | | Non Recurring |
-
| 3,572 |
-
| 138,152 | | Others | (4,549) | 950 | 3,599 |
-
| | | | Total Operating Expenses |
-
| 111,590 |
-
|
-
| | | | Operating Income or Loss | 11,414 | 20,393 | 5,737 | (156,984) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 20,910 | 20,393 | 5,737 | (156,984) | | Interest Expense | 5,328 | 1,975 | 2,193 | 2,803 | | Income Before Tax | 15,582 | 18,418 | 3,544 | (159,787) | | Income Tax Expense | 6,316 | 6,842 | 6,269 | (11,334) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 9,266 | 11,576 | (2,725) | (148,453) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| (287) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 9,266 | 11,576 | (2,725) | (148,740) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $6,012 | $11,576 | ($2,725) | ($148,740) |
|
0.01% Nasdaq 0.00%
Income Statement
